Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
14 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/14/3114749/0/en/Salarius-Pharmaceuticals-Granted-Additional-Extension-to-Regain-Compliance-with-Nasdaq-s-Stockholders-Equity-Standard.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112561/0/en/Salarius-Pharmaceuticals-Seclidemstat-Demonstrates-Supporting-Role-in-Inhibiting-Validated-Oncology-Target-LSD1-in-Two-Recently-Published-Studies.html
16 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/16/3062473/0/en/Salarius-Pharmaceuticals-Merger-Partner-Decoy-Therapeutics-Appoints-Renowned-MIT-Professor-Robert-S-Langer-to-its-Scientific-Advisory-Board.html
24 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/24/3047767/0/en/Salarius-Pharmaceuticals-Reports-2024-Financial-Results-and-Provides-Business-Update.html
03 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/03/3019460/0/en/Salarius-Pharmaceuticals-Announces-Patient-Enrollment-to-Resume-in-Investigator-initiated-Phase-1-2-Clinical-Trial-Using-Seclidemstat-with-Azacitidine-to-Treat-Hematologic-Cancers.html
13 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/13/3008457/0/en/Salarius-Pharmaceuticals-and-Decoy-Therapeutics-Announce-Definitive-Merger-Agreement.html
ABOUT THIS PAGE